Relationship between LAT1 Expression and Response to Platinum-based Chemotherapy in Non-small Cell Lung Cancer Patients with Postoperative RecurrenceKAIRA, Kyoichi; TAKAHASHI, Toshiaki; NAKAJIMA, Takashi et al.Anticancer research. 2011, Vol 31, Num 11, pp 3775-3782, issn 0250-7005, 8 p.Article

Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancerKAIRA, Kyoichi; NAITO, Tateaki; TSUYA, Asuka et al.Lung cancer. 2010, Vol 68, Num 1, pp 99-104, issn 0169-5002, 6 p.Article

Identification of actionable mutations in malignant pleural mesotheliomaSHUKUYA, Takehito; SERIZAWA, Masakuni; NAITO, Tateaki et al.Lung cancer. 2014, Vol 86, Num 1, pp 35-40, issn 0169-5002, 6 p.Article

Continuous Administration of EGFR-TKIs Following Radiotherapy after Disease Progression in Bone Lesions for Non-small Cell Lung CancerINOMATA, Minehiko; SHUKUYA, Takehito; ENDO, Masahiro et al.Anticancer research. 2011, Vol 31, Num 12, pp 4519-4523, issn 0250-7005, 5 p.Article

Efficacy and Safety of Platinum Combination Chemotherapy Re-Challenge for Relapsed Patients with Non-Small-Cell Lung Cancer after Postoperative Adjuvant Chemotherapy of Cisplatin plus VinorelbineIMAI, Hisao; SHUKUYA, Takehito; MURAKAMI, Haruyasu et al.Chemotherapy (Basel). 2013, Vol 59, Num 4, pp 307-313, issn 0009-3157, 7 p.Article

Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinomaIGAWA, Satoshi; MURAKAMI, Haruyasu; ENDO, Masahiro et al.Lung cancer. 2010, Vol 67, Num 2, pp 194-197, issn 0169-5002, 4 p.Article

The Impact of Clinical Outcomes According to EGFR Mutation Status in Patients with Locally Advanced Lung Adenocarcinoma Who Recieved Concurrent ChemoradiotherapyAKAMATSU, Hiroaki; KAIRA, Kyoichi; NAITO, Tateaki et al.American journal of clinical oncology. 2014, Vol 37, Num 2, pp 144-147, issn 0277-3732, 4 p.Article

Comparison of Vinorelbine plus Cisplatin and S-1 plus Cisplatin in Concurrent Chemoradiotherapeutic Regimens for Unresectable Stage III Non-small Cell Lung CancerSHUKUYA, Takehito; TAKAHASHI, Toshiaki; NAITO, Tateaki et al.Anticancer research. 2012, Vol 32, Num 2, pp 675-680, issn 0250-7005, 6 p.Article

Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancerONO, Akira; NAITO, Tateaki; TAKAHASHI, Toshiaki et al.Lung cancer. 2012, Vol 76, Num 3, pp 439-444, issn 0169-5002, 6 p.Article

Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failureSHUKUYA, Takehito; TAKAHASHI, Toshiaki; MITSUYA, Koichi et al.Lung cancer. 2011, Vol 74, Num 3, pp 457-461, issn 0169-5002, 5 p.Article

Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastasesTOKITO, Takaaki; SHUKUYA, Takehito; YAMAMOTO, Nobuyuki et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 6, pp 1493-1498, issn 0344-5704, 6 p.Article

Prognostic Factors and Clinical Outcome of Patients with Lung Adenocarcinoma with Carcinomatous MeningitisNAKAMURA, Yukiko; TAKAHASHI, Toshiaki; ENDO, Masahiro et al.Anticancer research. 2012, Vol 32, Num 5, pp 1811-1816, issn 0250-7005, 6 p., aArticle

Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reportsSHUKUYA, Takehito; TAKAHASHI, Toshiaki; ENDO, Masahiro et al.Cancer science. 2011, Vol 102, Num 5, pp 1032-1037, issn 1347-9032, 6 p.Article

L-Type Amino Acid Transporter 1 (LAT1) Expression in Malignant Pleural MesotheliomaKAIRA, Kyoichi; ORIUCHI, Noboru; KANAI, Yoshikatsu et al.Anticancer research. 2011, Vol 31, Num 12, pp 4075-4082, issn 0250-7005, 8 p.Article

Gefitinib Plus Paclitaxel after Failure of Gefitinib in Non-small Cell Lung Cancer Initially Responding to GefitinibSHUKUYA, Takehito; TAKAHASHI, Toshiaki; ENDO, Masahiro et al.Anticancer research. 2009, Vol 29, Num 7, pp 2747-2751, issn 0250-7005, 5 p.Article